The lead author is Carla Nasca, PhD, a postdoctoral scholar in McEwen's lab
This off-label use, the authors argue, is exposing deeper tensions between medical innovation, weight stigma, and the social value attached to thinness, as medication becomes a means of attaining social and aesthetic goals rather than improving health
That combination is real and worth evaluating against alternatives at higher price points
Formularies Formularies are drug lists that insurance companies use to show which medications they cover
Holst's work has shown that GLP-1 plays a critical role in maintaining stable blood glucose levels, preventing diabetes, and reducing the risk of cardiovascular disease
To continue reading either: Access your account Log in to your account to access your content on MIMS